Project Progress Report
Screening Visit
The written informed consent from each patient was taken before doing any study related
procedure. The demographic data of patients were recorded after obtaining the informed
consent. Previous and current medical history has been recorded. All laboratory investigations
(Hematology, Biochemistry) and CT scan were performed.
Baseline Visit
Eligibility criteria were reassessed and eligible patients were enrolled. They were randomized
to one of the treatment arms. One group received conventional therapy and other group
received Ayurvedic Treatment Protocol.
Patients were evaluated for headache days, pain intensity (VAS), headache frequency, duration
and associated symptoms. Patient visited the hospital at day 30, 60, 90, 120, 150, and 180 with
± 2 days allowance.
Dose schedule of the Ayurvedic Medicine
Name
Dose*
Anupan Schedule
150 g yogurt
50 ml water On empty stomach at Breakfast & Dinner
BD Water At breakfast & dinner
2 TDS Hot water After breakfast, lunch & dinner
OD Mishri At bed time
Narikela lavana (powder 1g) BD
Numax
(500 mg Capsule)
Rasonadi vati
(500 mg Tablet)
Godhanti mishran
(500 mg Tablet)
* OD- Once daily; BD – Both daily; TDS – Thrice daily
Randomized controlled clinical trial to evaluate prophylactic
6 properties of Ayu rv ed ic Treatment Protocol in
refractory and chronic migraine patients